Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy
Journal of Drugs in Dermatology · 01.11.2026 · 25 (11) · 1045-1050
DOI: 10.36849/jdd.9859 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.10.2026. Verfasst von Aliza Khuhro und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Immunomodulating Agents, Neoplasms, Dermatologic Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Khuhro, A., Kaufman, L., & Kobayashi, S. (2026). Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy. Journal of Drugs in Dermatology, 25(11), 1045-1050. https://doi.org/10.36849/jdd.9859
Vancouver
Khuhro A, Kaufman L, Kobayashi S. Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy. Journal of Drugs in Dermatology. 2026;25(11):1045-1050. doi:10.36849/jdd.9859
BibTeX
@article{Khuhro2026,
author = {Khuhro, Aliza and Kaufman, Lily and Kobayashi, Sonja},
title = {Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {11},
pages = {1045--1050},
doi = {10.36849/jdd.9859}
}
EUVIMED